# Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations

> **NCT00334711** · NA · COMPLETED · sponsor: **Royal Devon and Exeter NHS Foundation Trust** · enrollment: 50 (—)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Sulfonylurea

## Key facts

- **NCT ID:** NCT00334711
- **Lead sponsor:** Royal Devon and Exeter NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 50 (—)
- **Last updated:** 2006-11-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00334711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00334711, "Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00334711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*